Cardiovascular disease--the silent killer in rheumatoid arthritis.

Clinical Medicine : Journal of the Royal College of Physicians of London
Namita Kumar, David J Armstrong

Abstract

Rheumatoid arthritis (RA) is a multisystem disease with high rates of morbidity and mortality. In recent years, there has been increasing focus on the growing rates of cardiovascular disease (CVD) in RA, over and above expected levels allowing for 'traditional' risk factors. In this paper the impact of CVD in RA, the relative contributions of traditional risk factors and novel risk factors (including homocysteine, oxidised low-density lipoprotein, high-sensitivity C-reactive protein and leptin), and the need to address cardiovascular risk in the fight against premature death from coronary artery and stroke disease in RA are discussed.

Citations

Jun 9, 2009·The British Journal of Dermatology·A B AlexandroffD J Armstrong
Jul 28, 2012·The British Journal of Dermatology·P De MozziG A Johnston
Aug 8, 2009·The British Journal of Dermatology·A B Alexandroff, R A C Graham-Brown
Apr 24, 2010·The British Journal of Dermatology·A B AlexandroffG A Johnston

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.